Printer Friendly
The Free Library
4,550,514 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Leukemia topic

Subtopics (26)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Oerlikon Leybold Vacuum Aids Development of Tool To Identify Rare Cancer Cells. Oct 1, 2008 722
MuleSource Helps The Leukemia & Lymphoma Society Raise $10 Million in Two Months. Sep 23, 2008 682
New Leukemia Signal Could Point Way to Better Treatment, Stanford Researchers Find. Sep 17, 2008 728
"Blogging for Blood Cancer" Event Brings Bloggers Together for a Cure. Aug 11, 2008 623
OncoVista Innovative Therapies to Begin Enrolling Patients in a Phase I/II Study of Cordycepin in Patients with Refractory TdT-Positive Leukemia. Jul 22, 2008 437
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18. Jul 17, 2008 811
Rogers-O'Brien Construction Teams up with Tony's Room Foundation to Build "Clean Room" for Dallas Boy Battling Leukemia. Jul 16, 2008 418
Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial Of Novel PI3K Delta Inhibitor, CAL-101. Jul 10, 2008 455
Genome Sequencer FLX System plus NimbleGen Sequence Capture Arrays Help Unravel the Cryptic Genetic Changes in Hematological Malignancies. Jul 8, 2008 637
Young South Florida Leukemia Patient Represented by Hannon & Boyers Sues Makers of Contaminated Heparin, Saline. Jun 26, 2008 620
EVERYTHING'S CLICKING FOR EVAN HANDLER. Jun 23, 2008 628
Geron Presentations at the ASCO 2008 Annual Meeting. Jun 2, 2008 705
New Data on Bristol-Myers Squibb Oncology Compounds to Be Featured in More Than 100 Abstracts at ASCO 2008. May 15, 2008 507
Asuragen Launches Signature(R) LTx (Leukemia Translocation Panel) Globally. Apr 23, 2008 354
Xencor Presents Pre-Clinical Data for Anti-CD19 Antibody at AACR. Apr 15, 2008 554
ChemGenex Reports Oral Bioavailability of Omacetaxine and Expands on Mechanism of Action. Apr 14, 2008 725
Schwinn Signs First-ever National Bicycle Sponsorship of Team In Training. Company overview Mar 13, 2008 762
Seven-year-old helps children's hospital. Mass, Warren Feb 18, 2008 545
In Depth Report Analyzes Three Major and Intertwined Areas of Cancer R&D Antibody Drug Target Leukemias and Lymphomas. Dec 19, 2007 438
Payless Cellular Announces Giving Campaign To benefit The Leukemia & Lymphoma Society's Blood Cancer Research Programs. Dec 12, 2007 471
No new patients for Merck, Vertex trials. Brief article Dec 3, 2007 145
Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia. Meeuse, Jan J.; Sprenger, Herman G.; van Assen, Sander; Leduc, Dominique; Daenen, Simon M.G.J.; Aren Dec 1, 2007 1499
Tracking health and the environment: a pilot test of environmental public health indicators. Dreyling, Erin; Dederick, Elizabeth J.; Chari, Ramya; Resnick, Beth; Malecki, Kristen Chossek; Burke Author abstract Dec 1, 2007 3979
OXiGENE's ZYBRESTAT(TM) Reported to Have Anti-Leukemic Effects in Preclinical Studies Published in Blood. Nov 28, 2007 690
First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma. Nov 6, 2007 1402
The Leukemia & Lymphoma Society. Chin, Yoo Mi Nov 5, 2007 28
Cricket Communications sponsored a golf tournament Oct. 9 at the Santa Luz Golf Club to benefit the San Diego chapter of the Leukemia & Lymphoma Society. Glazer, Joyce Oct 22, 2007 97
infoUSA(R) Data Aids Seattle Leukemia Patient in Finding Bone Marrow Donor. Oct 2, 2007 794
The gift of life; Impulse to help gives a stranger chance to live. Sep 30, 2007 1575
Links fore leukemia. Sep 1, 2007 55
Alion Announces The Leukemia & Lymphoma Society's Light The Night Walk Will be the Kick-off Event for Alion Cares. Company overview Aug 27, 2007 672
Leukemia & Lymphoma Society. Chalk, Sean Aug 6, 2007 40
The Leukemia & Lymphoma Society. Aug 1, 2007 19
Leukemia and Lymphoma Society. Jul 16, 2007 37
Leukemia and Lymphoma Society. Jul 2, 2007 37
Umbilical Cord Blood Beats Marrow for Leukemia Transplants. Jul 1, 2007 167
Active fundraising: top 30 special events raised $1.43 billion. Nobles, Marla E. Jun 15, 2007 681
Cyclacel Pharmaceuticals to Host Conference Call to Review Sapacitabine Phase I Hematology Data on June 12, 2007. Jun 7, 2007 798
Scout out to collect blood; Leukemia patient, 5, inspires drive. May 3, 2007 500
The Leukemia & Lymphoma Society Selects Appian's Award-Winning BPM Suite to Automate Co-Pay Assistance Program. May 2, 2007 723
Bioenvision Files with EMeA for Label Extension of Evoltra(R). Feb 7, 2007 806
Biogen Idec Initiates Randomized, Registrational Trial of Lumiliximab for Chronic Lymphocytic Leukemia. Feb 7, 2007 946
ChemGenex Announces Granted U.S. Patent for Ceflatonin(R) Manufacturing. Feb 1, 2007 849
B-Cell Chronic Lymphocytic Leukemia Clinical Trial Initiated with Argos Therapeutics' AGS-005 Personalized Immunotherapy. Jan 31, 2007 584
Hana Biosciences Receives Orphan Drug Designation for Marqibo(R) (Vincristine Sulfate Liposomes Injection) for the Treatment of Acute Lymphoblastic Leukemia. Jan 16, 2007 863
Millbury girls keeping fallen coach's memory alive in division title run. Jan 14, 2007 718
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for INNO-406 for the Treatment of Chronic Myelogenous Leukemia. Jan 4, 2007 687
Aspartame not linked to cancer. Abegaz, Eyassu G. Jan 1, 2007 828
The Tyler Foundation: cricket stars gather for leukemia fundraiser. Forsythe, Kim Dec 22, 2006 912
Merck and Vertex Announce Start of Pivotal Phase 2 Clinical Trial for Investigational Aurora Kinase Inhibitor MK-0457 (VX-680) in Patients with Treatment-Resistant Forms of Advanced Leukemias. Dec 21, 2006 1333
Hana Biosciences Announces Filing of a Special Protocol Assessment (SPA) for Marqibo(R) (Vincristine Sulfate Liposomes Injection) in Relapsed Acute Lymphoblastic Leukemia. Dec 20, 2006 802
Dana-Farber/Harvard Cancer Center Implements Phase Forward's Electronic Data Capture Product for Pediatric Leukemia Study. Dec 13, 2006 1155
Xanthus Presents Preclinical Data Demonstrating Potent Symadex Activity in Leukemia Cells. Dec 11, 2006 621
Bioenvision Announces Latest Data on Evoltra(R) in Pediatric and Adult Leukemias. Dec 10, 2006 1153
Phase I/II Data Support Continued Development of Biogen Idec's Novel Anti-CD23 Antibody for Chronic Lymphocytic Leukemia. Dec 10, 2006 888
Bioenvision's Evoltra(R) Data Selected for Oral Presentation at ASH 2006 Annual Meeting. Dec 4, 2006 1121
Cyclacel Reports Interim Phase I Data for Sapacitabine in Patients with Advanced Leukemias or Myelodysplastic Syndromes. Nov 28, 2006 1048
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA. Nov 14, 2006 883
Review of Clinical Data from Gemin X Biotechnologies' GX15-070 Program Presented at the 24th Annual Chemotherapy Foundation Symposium. Nov 9, 2006 611
Identifying Emerging Leukemia Products & Key Areas of Pharmaceutical R&D. Oct 20, 2006 414
Palm Beach Area Chapter of the Leukemia & Lymphoma Society.. Oct 15, 2006 24
NCCN Updates Chronic Myelogenous Leukemia Guidelines. Oct 3, 2006 579
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia; Formal European Launch of Evoltra(R) at International Pediatric Oncology Meeting in Geneva. Sep 21, 2006 1098
Initial Patients Treated in Multinational Phase 2/3 Study of ChemGenex's Ceflatonin(R). Sep 20, 2006 805
Bioenvision to Expand into Japan and Southeast Asia; Japanese Health Officials Endorse Bioenvision's Leukemia Drug. Sep 18, 2006 912
ZIOPHARM Presents at European Society of Hematology Meeting; Updates ZIO-101 Clinical Development Strategy. Sep 14, 2006 565
Bioenvision to Formally Launch Evoltra(R) Throughout Europe; Bioenvision To Showcase Leukemia Drug At International Pediatric Oncology Conference. Sep 14, 2006 857
FIGHTING LEUKEMIA IS TEAMS' PASSION `LIGHT THE NIGHT' FUNDRAISER PLANNED. Aug 24, 2006 537
Hana Biosciences Initiates Marqibo(R) Phase II Clinical Trial in Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL). Aug 17, 2006 993
Dacogen(TM) (Decitabine) for Injection Receives U.S. Orphan Drug Designation for Patients with AML. Aug 10, 2006 780
Cell Signaling Technology Demonstrates the Discovery Capabilities of its PhosphoScan(R) Proteomics Platform with Identification of Novel Kinase Target in Leukemia. Aug 3, 2006 602
ChemGenex Announces Publication Of Two New Clinical Studies Supporting Expanded Opportunity For Ceflatonin(R) Beyond CML To Other Leukemias. Aug 2, 2006 948
Enzon Pharmaceuticals Announces Advancements in Its Oncology Pipeline; Oncaspar Phase I solid tumor trial begins; IND approved for rhMBL study. Aug 1, 2006 1078
Dacogen(TM) (Decitabine) For Injection Receives European Orphan Drug Designation for Patients With AML. Aug 1, 2006 784
FDA Approves Enzon's Oncaspar(R) for First-Line Use in Acute Lymphoblastic Leukemia. Jul 25, 2006 862
INNOVIVE Pharmaceuticals Enrolls First Patients in Phase I Study of INNO-406 in CML. Jul 17, 2006 782
FAMILY STRUCK TWICE BY TRAGEDY EVENT TO HELP FIGHT AGAINST LEUKEMIA. Jul 15, 2006 541
BRAVERY THROUGH ILLNESS BLOOD DRIVE SET FOR BOY SUFFERING FROM LEUKEMIA. Jul 14, 2006 478
MGI PHARMA UNVEILS DACOGEN (DECITABINE) FOR INJECTION. Jul 1, 2006 779
ChemGenex Teams with MolecularMD to Identify CML Patients with the T315I Drug Resistance Mutation for Phase 2/3 Clinical Trial of Ceflatonin(R). Jun 26, 2006 839
ChemGenex Investigators Present Data at European Hematology Association Meeting Showing Success of Ceflatonin for Treating CML Patients Resistant to Gleevec(R). Jun 19, 2006 705
Cyclacel Begins Phase I Pharmacologic Study of Oral Sapacitabine in Patients with Advanced Leukemias. Jun 15, 2006 820
ChemGenex Launches Multinational Phase 2/3 Study for CML Patients with the T315I Mutation; Reports Preclinical Activity in T315I+ CML. Jun 13, 2006 1240
Phase II Clinical Trial of NeoPharm's LE-SN38 Initiated by NCI CALGB in Patients with Metastatic Colorectal Cancer; First Patients Treated. May 30, 2006 1339
Leukemia & Lymphoma Society. May 29, 2006 23
MGI PHARMA Announces Commercial Availability of Dacogen(TM) (Decitabine) for Injection. May 26, 2006 952
Hana Biosciences Receives Orphan Drug Designation for Talotrexin (PT-523), For the Treatment of Acute Lymphoblastic Leukemia. May 22, 2006 931
Pluristem Files Patent Application For PLX-1, Intended as an Innovative Stem Cell Solution For Improved Engraftment During Bone Marrow Transplantation. May 8, 2006 585
Dreams Do Come True for Six Families in Need; Select Comfort Fulfills Dreams of Families Staying at Nationwide Ronald McDonald Houses(R). May 4, 2006 1243
U.S. FDA Approves Dacogen(TM) (Decitabine) for Injection; Dacogen(TM) Approved for Patients with all FAB Classifications of MDS; Commercial Launch Planned For Late May. May 3, 2006 1651
Five-year, Government funded, epidemiology study confirms safety of aspartame. May 1, 2006 438
Pluristem Initiates Pre-Clinical Study for PLX-1, an Innovative Stem Cell Solution for Improved Engraftment During Bone Marrow Transplantation. Apr 24, 2006 704
Power3 Medical Files Application with U.S. Patent Office for Test to Determine Resistance to Gleevec, a Leading Leukemia Drug; Power3 Also Offers Design Specifications to Overcome Resistance to Drug. Apr 24, 2006 627
Research and Markets: Acute Leukaemia's Persistent Unmet Needs Confer Significant Commercial Opportunity; Commercial Opportunities within the Acute Leukaemia Market are Rife. Apr 12, 2006 334
Bioenvision's Evoltra(R) Achieves High Response Rates in Adult AML; New Interim Data Presented from Phase I/II Clinical Study. Apr 5, 2006 933
ZIOPHARM Presents ZIO-201/202/203 Preclinical Data at AACR; Anti-Cancer Activity in Leukemia, Pancreas, and Prostate Cancers. Apr 3, 2006 425
SGX stock flies. Weeks, Katie Brief article Apr 3, 2006 193
SGX Pharmaceuticals forms collaboration to commercialize BCR-ABL inhibitors for the treatment of chronic myelogenous leukemia. Apr 1, 2006 885
The Leukemia and Lymphoma Society. Mar 27, 2006 41
SGX Pharmaceuticals forms collaboration to commercialize BCR-ABL inhibitors for the treatment of chronic myelogenous leukemia. Mar 1, 2006 885

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles